XBiotech Inc


Prices are adjusted according to historical splits.

XBiotech Inc Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
$103.19 million
Book Value:
Revenue TTM:
$4.01 million
Operating Margin TTM:
Gross Profit TTM:
$3.36 million
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

XBiotech Inc had its IPO on 2015-04-15 under the ticker symbol XBIT.

The company operates in the Healthcare sector and Biotechnology industry. XBiotech Inc has a staff strength of 85 employees.

Stock update

Shares of XBiotech Inc opened at $3.25 at the start of the last trading session i.e. 2023-03-22.

The stocks traded within a range of $3.25 - $3.49, and closed at $3.35.

This is a +2.76% increase from the previous day's closing price.

A total volume of 12,365 shares were traded at the close of the day’s session.

In the last one week, shares of XBiotech Inc have increased by +2.76%.

XBiotech Inc's Key Ratios

XBiotech Inc has a market cap of $103.19 million, indicating a price to book ratio of 0.4053 and a price to sales ratio of 11.901.

In the last 12-months XBiotech Inc’s revenue was $4.01 million with a gross profit of $3.36 million and an EBITDA of $-31876000. The EBITDA ratio measures XBiotech Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, XBiotech Inc’s operating margin was -860.1% while its return on assets stood at -8.27% with a return of equity of -12.91%.

In Q4, XBiotech Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 93.3%.

XBiotech Inc’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at $-1.05 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into XBiotech Inc’s profitability.

XBiotech Inc stock is trading at a EV to sales ratio of 0.686 and a EV to EBITDA ratio of 3.9436. Its price to sales ratio in the trailing 12-months stood at 11.901.

XBiotech Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$246.10 million
Total Liabilities
$4.07 million
Operating Cash Flow
Capital Expenditure
Dividend Payout Ratio

XBiotech Inc ended 2023 with $246.10 million in total assets and $0 in total liabilities. Its intangible assets were valued at $246.10 million while shareholder equity stood at $240.40 million.

XBiotech Inc ended 2023 with $0 in deferred long-term liabilities, $4.07 million in other current liabilities, 267325000.00 in common stock, $-27749000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $157.31 million and cash and short-term investments were $157.31 million. The company’s total short-term debt was $0 while long-term debt stood at $0.

XBiotech Inc’s total current assets stands at $219.84 million while long-term investments were $0 and short-term investments were $60.17 million. Its net receivables were $1.22 million compared to accounts payable of $2.41 million and inventory worth $0.

In 2023, XBiotech Inc's operating cash flow was $-3907000.00 while its capital expenditure stood at $375000.

Comparatively, XBiotech Inc paid $0 in dividends in 2023.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

XBiotech Inc stock is currently trading at $3.35 per share. It touched a 52-week high of $9.37 and a 52-week low of $9.37. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $3.79 and 200-day moving average was $4.13 The short ratio stood at 2.14 indicating a short percent outstanding of 0%.

Around 3686.7% of the company’s stock are held by insiders while 1303.9% are held by institutions.

Frequently Asked Questions About XBiotech Inc

The stock symbol (also called stock or share ticker) of XBiotech Inc is XBIT

The IPO of XBiotech Inc took place on 2015-04-15

Similar Industry Stocks (Biotechnology)

Last Price

Most Active

Last Price
Tesla Inc (TSLA)

Top Gainers

Last Price

Top Losers

Last Price


XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.


5217 Winnebago Lane, Austin, TX, United States, 78744